BioChain Real Assets is a subsidiary of Capital Hall Partners, a privately-held real estate and development firm with a 15+ year track record of successful transactions.
The team at BioChain is focused on developing R&D labs, bio-manufacturing facilities (referred to as Good Manufacturing Process, cGMP), and biotech/pharmaceutical facilities across the U.S. Our business helps support and facilitate the rapid development of cutting-edge medical therapies.
The Life Sciences industry is innovating at a pace like none other in history, changing lives and improving health outcomes with each new innovation. Our goal is to create and offer space to companies leading the charge.
Company Details
- Founded
- -
- Address
- 101 Arch Street, Boston,ma 02210,united States
- Industry
- Real Estate
- Website
- https://www.biochainre.com/
- Keywords
- commercial real estate, mergers and acquisitions, real estate investment strategy, asset management, financial modeling, capital and partnership structuring, project management, life sciences real estate.
- HQ
- Boston, MA
- Competitors
- Bradley Hall | North East, Capital Hall Partners.
Biochain Real Assets Questions
Biochain Real Assets's website is https://www.biochainre.com/
Biochain Real Assets's LinkedIn profile is https://www.linkedin.com/company/biochain-real-assets
Biochain Real Assets's industry is
Real Estate
Biochain Real Assets's top competitors are
Bradley Hall | North East,
Capital Hall Partners.
Biochain Real Assets's categories are Real Estate
Biochain Real Assets's founding year is 2022
